• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种单克隆抗体 MLS128(针对 Tn 抗原)和 1H7(针对胰岛素样生长因子-I 受体)对结肠癌细胞生长的影响。

Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.

机构信息

Department of Applied Biochemistry, Tokai University School of Engineering, Hiratsuka, Kanagawa, Japan.

出版信息

Biosci Trends. 2012 Dec;6(6):303-12.

PMID:23337790
Abstract

MLS128 is an anti-carbohydrate monoclonal antibody (mAb) that binds three or two consecutive Tn-antigens. MLS128 bound 110-210 kDa glycoproteins (GPs) and inhibited the growth of LS180 and HT29 colon and MCF-7 breast cancer cells. One possible mechanism of MLS128's inhibition of growth may be via insulin-like growth factor-I receptor (IGF-IR) down-regulation (Morita et al. BioScience Trends. 2009; 3:32-37). The current study examined the role of IGF-IR signaling in the growth of colon cancer cells and its possible interaction with MLS128-induced inhibition of cell growth in LS180, LS174T, and HT29 human colon cancer cells treated with MLS128 or anti-IGF-IR 1H7. Both MLS128 and 1H7 treatment significantly inhibited the growth of colon cancer cells. All three colon cancer cell lines expressed IGF-IR. Their growth was in part IGF-I dependent, but inhibition by MLS128 was independent of IGF-IR signaling. All of the colon cancer cell lines expressed an 110kDa GP for MLS128 binding, but MCF-7 cells expressed MLS128-detectable bands with higher molecular masses. 1H7 treatments caused down-regulation of IGF-IR but did not affect 110kDa GP levels. MLS128 treatments resulted in partial disappearance of the 110kDa band but did not affect IGF-IR levels. Western blotting analyses of colon and breast cancer cell lysates revealed that colon and breast cancer cells differed significantly in patterns of expression of growth-related molecules while colon cancer cells were similar but distinctive. In conclusion, MLS128 inhibited the growth of colon cancer cells by binding to the 110kDa GP receptor. Inhibition of growth by MLS128 did not appear to affect IGF-IR signaling and instead only affected other growth signaling pathways.

摘要

MLS128 是一种抗碳水化合物单克隆抗体 (mAb),可与三个或两个连续的 Tn 抗原结合。MLS128 结合 110-210 kDa 糖蛋白 (GP),并抑制 LS180 和 HT29 结肠和 MCF-7 乳腺癌细胞的生长。MLS128 抑制生长的一种可能机制可能是通过胰岛素样生长因子-I 受体 (IGF-IR) 下调(Morita 等人,BioScience Trends. 2009; 3:32-37)。本研究探讨了 IGF-IR 信号在结肠癌细胞生长中的作用及其与 MLS128 诱导的 LS180、LS174T 和 HT29 人结肠癌细胞生长抑制的相互作用,这些细胞用 MLS128 或抗 IGF-IR 1H7 处理。MLS128 和 1H7 处理均显著抑制结肠癌细胞的生长。三种结肠癌细胞系均表达 IGF-IR。它们的生长部分依赖于 IGF-I,但 MLS128 的抑制与 IGF-IR 信号无关。所有结肠癌细胞系均表达 MLS128 结合的 110kDa GP,但 MCF-7 细胞表达 MLS128 可检测到更高分子量的带。1H7 处理导致 IGF-IR 下调,但不影响 110kDa GP 水平。MLS128 处理导致 110kDa 带部分消失,但不影响 IGF-IR 水平。对结肠和乳腺癌细胞裂解物的 Western 印迹分析表明,结肠和乳腺癌细胞在生长相关分子的表达模式上存在显著差异,而结肠癌细胞相似但具有特征性。总之,MLS128 通过与 110kDa GP 受体结合抑制结肠癌细胞的生长。MLS128 对生长的抑制似乎不影响 IGF-IR 信号,而仅影响其他生长信号通路。

相似文献

1
Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.两种单克隆抗体 MLS128(针对 Tn 抗原)和 1H7(针对胰岛素样生长因子-I 受体)对结肠癌细胞生长的影响。
Biosci Trends. 2012 Dec;6(6):303-12.
2
Characterization of anti-Tn-antigen MLS128 binding proteins involved in inhibiting the growth of human colorectal cancer cells.鉴定参与抑制人结直肠癌细胞生长的抗 Tn 抗原 MLS128 结合蛋白。
Biosci Trends. 2013 Oct;7(5):221-9.
3
Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.抗 Tn 单克隆抗体 MLS128 抑制癌细胞生长。
Biosci Trends. 2009 Feb;3(1):32-7.
4
Mechanisms of antibody-mediated insulin-like growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast cancer cells.抗体介导的 MCF-7 乳腺癌细胞胰岛素样生长因子 I 受体 (IGF-IR) 下调的机制。
Biosci Trends. 2009 Aug;3(4):131-8.
5
Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.表面等离子体共振和 NMR 分析 MLS128 抗 Tn 抗原单克隆抗体与两个或三个连续 Tn 抗原簇的结合。
J Biochem. 2012 Mar;151(3):273-82. doi: 10.1093/jb/mvr138. Epub 2011 Dec 8.
6
MLS128 antibody-induced suppression of colon cancer cell growth is mediated by a desmocollin and a 110 kDa glycoprotein.MLS128 抗体诱导的结肠癌细胞生长抑制是由桥粒糖蛋白和一个 110kDa 糖蛋白介导的。
Biosci Trends. 2019 Jul 22;13(3):216-224. doi: 10.5582/bst.2019.01074. Epub 2019 Jun 5.
7
Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.胰岛素样生长因子I受体单克隆抗体对人结肠癌细胞的生长抑制作用。
Cancer Invest. 2008 Apr-May;26(3):230-6. doi: 10.1080/07357900701508975.
8
Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells.人结肠癌细胞中表达的抗Tn抗原MLS128结合糖蛋白对蛋白酶的敏感性。
Biosci Trends. 2015 Feb;9(1):49-55. doi: 10.5582/bst.2014.01127.
9
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.一种针对I型胰岛素样生长因子(IGF)受体的嵌合人源化单链抗体使乳腺癌细胞对IGF-I的促有丝分裂作用产生抗性。
Cancer Res. 2003 Feb 1;63(3):627-35.
10
Construction and characterization of single-chain antibodies against human insulin-like growth factor-I receptor from hybridomas producing 1H7 or 3B7 monoclonal antibody.从产生1H7或3B7单克隆抗体的杂交瘤构建抗人胰岛素样生长因子-I受体的单链抗体并进行表征。
J Biochem. 2008 Jan;143(1):9-19. doi: 10.1093/jb/mvm192. Epub 2007 Oct 23.

引用本文的文献

1
Deciphering Protein O-GalNAcylation: Method Development and Disease Implication.解析蛋白质O-连接N-乙酰半乳糖胺糖基化:方法开发与疾病关联
ACS Omega. 2023 May 24;8(22):19223-19236. doi: 10.1021/acsomega.3c01653. eCollection 2023 Jun 6.
2
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.胰岛素样生长因子 1 受体(IGF-1R)通路激活可作为来那替尼逆转 ER 阳性乳腺癌他莫昔芬耐药的潜在生物标志物。
Int J Cancer. 2020 Apr 15;146(8):2348-2359. doi: 10.1002/ijc.32668. Epub 2019 Oct 6.
3
Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.
针对Tn和唾液酸化Tn抗原的抗体开发面临的挑战。
Biomolecules. 2015 Aug 11;5(3):1783-809. doi: 10.3390/biom5031783.
4
Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.唾液糖缀合物在结直肠癌诊断和治疗中的临床病理应用价值
World J Gastroenterol. 2014 May 28;20(20):6123-32. doi: 10.3748/wjg.v20.i20.6123.
5
Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.Tn和唾液酸化Tn抗原,作为人类疾病标志物的异常O-糖组学。
Proteomics Clin Appl. 2013 Oct;7(9-10):618-31. doi: 10.1002/prca.201300024. Epub 2013 Sep 9.